CVI Investments, Inc. 13D/13G Filings for ReShape Lifesciences Inc. (RSLS)

CVI Investments, Inc. 13D and 13G filings for ReShape Lifesciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-21
10:33 am
Purchase
2025-02-1813GReShape Lifesciences Inc.
RSLS
CVI Investments, Inc.344,626
9.900%
344,626increase
(New Position)
Filing